
Celanese (CE) is back on many investors’ radars after a stretch of mixed returns, with losses over the past year but gains over the past 3 months and year to date. This pattern is prompting fresh questions about valuation and business momentum.
See our latest analysis for Celanese.
The recent 90 day share price return of 33.93% and year to date gain of 33.14% contrast with a 1 year total shareholder return decline of 5.34%, pointing to improving momentum after a tougher stretch for long term holders.
If you are weighing opportunities beyond chemicals and materials, this could be a useful moment to broaden your search with a curated list of 20 top founder-led companies
With the stock up strongly over the past 3 months but still showing a weaker 1 year and multi year record, the key question now is whether Celanese is still priced at a discount or if the market already reflects expectations for the company.
Celanese’s most followed narrative assigns a fair value of $51.50, compared with the latest close at $56.13. This frames the recent rebound against a slightly richer valuation and a detailed earnings recovery story.
Celanese is positioned to benefit from the shift toward lightweight and fuel-efficient solutions in automotive and aerospace, with the upcoming wave of new EV launches by Western OEMs and continuing demand for high-performance polymers expected to reignite volume growth and revenues as end-market demand normalizes.
Read the complete narrative. Read the complete narrative.
Want to see what is baked into that fair value? Revenue expectations barely move, yet the narrative leans heavily on a sharp margin reset and a future earnings multiple below the broader Chemicals group. The full breakdown shows exactly how those moving parts fit together.
Result: Fair Value of $51.50 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story can change quickly if weak demand in acetyl and engineered materials persists, or if high debt and interest costs limit the impact of cost cuts.
Find out about the key risks to this Celanese narrative.
The most followed narrative sees Celanese as about 9% overvalued at $56.13 versus a fair value of $51.50, based on earnings assumptions and a future P/E of roughly 10x. Yet Simply Wall St’s DCF model points to a value of $107.97, suggesting the shares trade at a steep discount instead. Which set of assumptions feels more realistic to you?
Look into how the SWS DCF model arrives at its fair value.
Seeing both risks and rewards in Celanese so far? Move quickly from headline takeaways to your own view by weighing its 3 key rewards and 1 important warning sign
If Celanese has sharpened your interest, this is the moment to widen your watchlist with focused stock ideas that match how you like to invest.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com